Details of the Drug

General Information of Drug (ID: DMPB9MY)

Drug Name

6-Methoxy-4-morpholin-4-yl-chromen-2-one

Synonyms

CHEMBL175510; NU-7031; 79105-88-7; 6-methoxy-4-morpholin-4-yl-chromen-2-one; 6-methoxy-4-morpholino-2H-chromen-2-one; SCHEMBL3666851; BDBM50159679

Indication

Disease Entry	ICD 11	Status	REF
Discovery agent	N.A.	Investigative	[1]
------------------------------------------------------------------------------------

Drug Type

Small molecular drug

Structure

3D MOL

2D MOL

#Ro5 Violations (Lipinski): 0

Molecular Weight (mw)

261.269

Logarithm of the Partition Coefficient (xlogp)

1.3

Rotatable Bond Count (rotbonds)

2

Hydrogen Bond Donor Count (hbonddonor)

0

Hydrogen Bond Acceptor Count (hbondacc)

5

Chemical Identifiers

Formula: C14H15NO4
IUPAC Name: 6-methoxy-4-morpholin-4-ylchromen-2-one
Canonical SMILES: COC1=CC2=C(C=C1)OC(=O)C=C2N3CCOCC3
InChI: InChI=1S/C14H15NO4/c1-17-10-2-3-13-11(8-10)12(9-14(16)19-13)15-4-6-18-7-5-15/h2-3,8-9H,4-7H2,1H3
InChIKey: UEDWCBYLFYRZFY-UHFFFAOYSA-N

Cross-matching ID

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
DNA-dependent protein kinase catalytic (PRKDC)	TTK3PY9	PRKDC_HUMAN	Inhibitor	[1]

------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA)

Jump to Detail Molecular Interaction Atlas of This Drug

References

1	Selective benzopyranone and pyrimido[2,1-a]isoquinolin-4-one inhibitors of DNA-dependent protein kinase: synthesis, structure-activity studies, and... J Med Chem. 2005 Jan 27;48(2):569-85.